Molecule Details
| InChIKey | IXHBTMCLRNMKHZ-LBPRGKRZSA-N |
|---|---|
| Compound Name | Levobunolol |
| Canonical SMILES | CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.57 |
| Source | ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB01210 |
|---|---|
| Drug Name | Levobunolol |
| CAS Number | 47141-42-4 |
| Groups | approved |
| ATC Codes | S01ED03 |
| Description | A nonselective beta-adrenoceptor antagonist used in the treatment of glaucoma. |
Categories: Adrenergic Agents Adrenergic Antagonists Adrenergic beta-Antagonists Agents causing hyperkalemia Alcohols Amines Amino Alcohols Antiglaucoma Preparations and Miotics Autonomic Agents Beta-adrenergic Agents Bradycardia-Causing Agents Bunolol Cytochrome P-450 CYP2D6 Substrates Cytochrome P-450 Substrates Hypotensive Agents Naphthalenes Neurotransmitter Agents Ophthalmologicals Peripheral Nervous System Agents Phenoxypropanolamines Propanolamines Propanols Sensory Organs Sympatholytics Tetrahydronaphthalenes
Cross-references: ChEBI: 6438 CHEMBL1201237 ChemSpider: 36089 Drugs Product Database (DPD): 1848 C07914 PharmGKB: PA164747027 PubChem:39468 PubChem:46507518 RxCUI: 1813 Therapeutic Targets Database: DAP000303 Wikipedia: Levobunolol ZINC: ZINC000003830339